AGRX stock forecast
Our latest prediction for Agile Therapeutics Inc's stock price was made on the Aug. 31, 2022 when the stock price was at 0.40$.
In the short term (2weeks), AGRX's stock price should underperform the market by -2.28%. During that period the price should oscillate between -11.94% and +17.24%.
In the medium term (3months), AGRX's stock price should outperform the market by 1.22%. During that period the price should oscillate between -25.82% and +23.85%.
Get email alertsCreate a solid portfolio with AGRX
About Agile Therapeutics Inc
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
At the moment the company generates 5M USD in revenues.
On its last earning announcement, the company reported a loss of -7.07$ per share.
The book value per share is 0.76$
Three months stock forecastAug. 31, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
5M | -92.53% | -65M | -1188.37% | -70M | -7.07 | - | - | 12M | 0.76 | - | - | - |